Based On The Current API Price, Co Is Looking To Achieve ₹4,000 Cr Revenue By FY27: Aarti Drugs

(7:50)

Aarti Drugs share latest news,Buy or not ? Aarti drugs share news today

(1:43)

Why aarti drugs stock going up ? Detailed fundamental analysis

(23:4)

Should Be Able To Cross 13% EBITDA Margin In H2FY25: Aarti Drugs | CNBC TV18

(9:43)

Aarti Drugs CFO On The Expansions Plans Post Fund Raise

(5:58)

Aarti Drugs : Fundamental Analysis : by CA Ravinder Vats

(20:1econd)

Aarti drugs Share Latest News | Aarti drugs Share news today | Aarti drugs Share price today |

(2:11)

We Saw Volume Decline In Exports Due To Ongoing Geopolitical Tensions: Aarti Drugs | CNBC TV18

(8:6)

Aarti Drugs Secures USFDA Approval for Tarapur API Facility, Eyes ₹80-85 Crore Boost

(6:44)

🥊AARTI DRUGS vs AARTI PHARMALABS | Which is Best? High Growth??📈📈💊

(43:12)

aarti drugs ltd share,aarti drugs share latest news,aarti drugs share news today

(2:31)

Aarti drugs Ltd | Fundamentals and technical analysis | #stockmarket #stocks

(4:47)

Aarti Drugs Ltd: Stock Recommendation, Company's Fundamentals, \u0026 Target By Sandeep Jain

(4:8)

AARTI Drugs share latest news,aarti drugs share analysis,aarti drugs share price target,

(1:6)

'Expect The CDMO Business To Witness Recovery In H2': Laurus Lab's Founder \u0026 CEO On Talking Point

(13:17)

JB Pharma Strengthens Its Position in Gastroenterology with Launch Of RANRAFT

(1:30)

Dr. Reddy’s Celevida – The Right Nutrition Partner

(20)

Disruption Of 12 Days Due To Fire Incident; Assets Impacted Are Less Than ₹1 Cr: Aarti Drugs

(6:55)

AARTI DRUGS SHARE LATEST NEWS TODAY,AARTI DRUGS SHARE ANALYSIS,AARTI DRUGS SHARE BREAKOUT

(1:21)

Aarti Drugs CFO Adhish Patil Discusses March Results, Profit Margins and Market Trends

(5:13)

Aarti Drugs Greenlights Massive Buyback: 6.65 Lakh Shares at ₹900 Each!

(39)

Aarti Drugs Q1 Results | बिजनेस आउटलुक पर कंपनी के CFO, Adish Patil से खास बातचीत

(5:47)